FIGURE 1. Role of MDM proteins in retinoblastoma.

From the following article:

Cancer biology: Second step to retinal tumours

Valerie A. Wallace

Nature 444, 45-46(2 November 2006)

doi:10.1038/444045a

BACK TO ARTICLE

a, Under normal conditions, levels of p53 protein are kept low, partly through negative regulation by MDM proteins. MDM2 is an enzyme that tags p53 with a ubiquitin molecule (Ub), thereby promoting p53 degradation. MDMX also interacts physically with p53 and inhibits its gene-regulatory activity. b, Mutation of the retinoblastoma gene (Rb) results in increased production of the p14ARF protein, which in turn leads to inactivation of MDM2, thus promoting p53 pathway activation. This leads to cell-cycle arrest or cell death, or facilitates DNA repair. c, Increased expression of MDM proteins in the absence of Rb blocks activation of p53, leading to survival of the abnormal cells and tumour progression. Independently of p53, interactions of MDM with other proteins that regulate cell division, survival and differentiation could also promote tumour progression13.

Figures & Tables index
BACK TO ARTICLE